Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.
about
Neurocircuitry of addictionRole of kappa-opioid receptors in stress and anxiety-related behavior.Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in ratsRole of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.Progress in corticotropin-releasing factor-1 antagonist development.The role of CRF and CRF-related peptides in the dark side of addiction.Molecular and genetic substrates linking stress and addictionRobust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence.Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking BehaviorNeurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesiaNeurobiology of dysregulated motivational systems in drug addiction.Corticotropin releasing factor: a key role in the neurobiology of addictionHypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.The dark side of emotion: the addiction perspectiveTranslational and reverse translational research on the role of stress in drug craving and relapse.Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism.Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systemsThe dark side of food addiction.Addiction and brain reward and antireward pathways.The effect of intermittent alcohol vapor or pulsatile heroin on somatic and negative affective indices during spontaneous withdrawal in Wistar rats.Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.Episodic Social Stress-Escalated Cocaine Self-Administration: Role of Phasic and Tonic Corticotropin Releasing Factor in the Anterior and Posterior Ventral Tegmental Area.Motivational Processes Underlying Substance Abuse Disorder.Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.Is it stress? The role of stress related systems in chronic food restriction-induced augmentation of heroin seeking in the ratAddiction is a Reward Deficit and Stress Surfeit Disorder.Neurobiological substrates for the dark side of compulsivity in addiction.Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses.Addiction as a stress surfeit disorder.Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.Development of pharmacotherapies for drug addiction: a Rosetta stone approach.Emerging targets for addiction neuropharmacology: From mechanisms to therapeuticsBrain stress systems in the amygdala and addiction.The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviorsThe role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seekingPublication trends in addiction research.Modeling the development of drug addiction in male and female animals.Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.Craving, context and the cortex.
P2860
Q24647156-E4178396-B108-4412-ADA9-84C17FA23986Q26991739-D859F61E-DBB8-420C-9936-5E8538D8177CQ30431860-7C8E9976-1EAF-45EB-8815-00428F83D391Q30468942-7A952D44-72B6-480C-B3A1-0A0EA75DC394Q30475627-D95C8614-A6CB-4483-BA3B-F3E471085DA4Q30476985-E80A5B9A-AE84-4230-8FAE-7B160C1B3143Q30476986-0566CB50-12DC-423A-B3C4-C79F76B520F8Q30521108-9DADE365-37FA-463A-9A3D-9922884B8893Q33572392-E5262255-B076-4409-82C2-7291D1957004Q33616639-F9149B58-18D0-4277-8D5D-0E5DF505AD10Q33754272-A81B350E-5794-4A1A-A6C7-DFE1387CED4FQ33915824-48CFCFEE-27E5-4848-9597-D377CBED41CCQ34421204-52F9C5B2-2A1F-41A9-BA2A-9E1C40BB12E2Q35199989-A5A2C9EE-1843-4243-AF62-160A3CF00C4EQ35235813-15D50A8F-7F04-4EA3-8100-50B2921E7C8FQ35332832-B15B2CB7-4BD6-4141-BB81-B0D9E7CAC6F8Q35685680-177753CB-6C2B-4325-9C5A-6AC22259AFD9Q35783139-C6B4862E-B940-46D0-BBE8-C9AE182BFB0EQ35832522-61471B6A-8E6B-45DD-9A5F-E28883554E24Q35995170-22CB2A95-37C5-4F73-901E-1ADFA59A683FQ36164923-499E7FC0-057B-421D-AF6E-B4638CB50F2DQ36736335-27442C1E-DF03-4D45-BAD6-027DEE894996Q36768435-7249405D-01DC-4D39-BAA1-090444FD529AQ36853330-8EA44D6C-0421-41F1-833F-6D8AEA5D85CFQ36900018-15440192-B849-48A7-B5C3-7E42B4DB2D9FQ36907029-23D48A36-0611-49F7-A877-BA82B7D0F8AAQ37061135-DD8F8319-69C6-4113-BF4E-7B8B7DB2EA06Q37088658-B78EBB26-10FE-482D-9936-4CB11833A681Q37302152-E398E973-97F8-4922-8055-13C5973B6DA8Q37315976-EF031988-AEDA-459F-8C4A-768A594DEF65Q37336313-4A1FFAC4-2C60-4CF3-BD5A-6DB7C3B4B449Q37383571-D8B0507A-8B1F-419E-8427-8D58714650C8Q37397620-15E90D93-7297-457E-8247-591284B1D6ADQ37415172-82028523-D20B-4626-945B-61E7BB0EBC27Q37589122-0E2E2811-9AB3-4DBC-ABCF-995AE88FDFE3Q37642405-ECFC9A30-CD29-4BDB-82B6-6B986EE08703Q37935107-9D99DE88-7CBB-470B-91BF-C27B16BEAFFDQ38669858-1858E8D0-29F1-4AF5-83A3-FE186962C7A9Q39066739-49446C06-34BB-4257-9FE6-143650391FD1Q42905150-5A0935A8-ADC7-4CF6-8E5D-6FA7C0D45254
P2860
Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Corticotropin-releasing factor ...... ng- but not short-access rats.
@en
Corticotropin-releasing factor ...... ng- but not short-access rats.
@nl
type
label
Corticotropin-releasing factor ...... ng- but not short-access rats.
@en
Corticotropin-releasing factor ...... ng- but not short-access rats.
@nl
prefLabel
Corticotropin-releasing factor ...... ng- but not short-access rats.
@en
Corticotropin-releasing factor ...... ng- but not short-access rats.
@nl
P2093
P2860
P50
P1433
P1476
Corticotropin-releasing factor ...... ng- but not short-access rats.
@en
P2093
Cindy K Funk
Eric P Zorrilla
George F Koob
Kenner C Rice
Scott A Chen
P2860
P304
P356
10.1111/J.1369-1600.2008.00142.X
P577
2009-04-01T00:00:00Z